Autoinjectors Market Forecast up to 2024

Autoinjectors Market – Global Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024

Overview:
The medical devices that are primarily used for the self-injection of drugs, classically life-saving drugs, are known as autoinjectors. These devices are gaining increased importance for the management of anaphylaxis, diabetes, rheumatoid arthritis, multiple sclerosis, and others. Autoinjectors are relaxed to use and proposed for self-administration by individuals either at caretakers premises or at home.

Raising prevalence of serious medical conditions such as anaphylaxis & other food allergies, advancements in the autoinjectors technology, increasing demand for home healthcare, and the rising need for self-injectors are the factors aiding the growth of the autoinjectors market. Novel formulations of drugs and advancements in drug delivery systems along with favorable government regulations are providing an opportunity for the market growth. However, recent product recalls by the companies and the availability of substitutes for autoinjectors are hampering the market growth.

Market Analysis: The “global autoinjectors market” is estimated to witness a CAGR of 17.1% during the forecast period 2018–2024. The autoinjectors market is analyzed based on three segments – products, applications, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the autoinjectors market, followed by Europe, Asia Pacific, and Rest of the World. More than 65% of the market is occupied by North America, with the US being the major contributor to the market growth.

Product Analysis: Based on the products, the market is segmented into disposable autoinjectors and reusable autoinjectors. Disposable autoinjectors hold dominant market share and is also the fastest growing segment in the market.

Application Analysis: Based on the application areas, the market is segmented into anaphylaxis, multiple sclerosis, rheumatoid arthritis, diabetes, and others. The market is dominated by anaphylaxis owing to a high prevalence rate globally. The fastest growing segment of the market is rheumatoid arthritis due to increased development of novel drugs for the treatment of the condition.

Key Players: The major players in the market are Mylan NV, Novartis AG, Amgen, Inc., Becton Dickinson and Company, Bayer AG, and Eli Lilly & Company Ltd. The other key players in the market include Ypsomed Holding AG, Biogen Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical, Antares Pharma, Inc., Johnson and Johnson, and AbbVie, Inc.

Competitive Analysis: The key manufacturers of autoinjectors are concentrating on innovative marketing tactics to expand the reach of their products globally. Increasing awareness campaigns and price reduction of branded devices are among the strategies used by the leading companies to manage intense competition in the market. Many companies are rebranding their autoinjectors with worthwhile reductions in the price. In December 2016, Mylan launched the generic version of EpiPen to provide autoinjector for customers at lesser prices. This approach ought to help the company in targeting a larger customer pool, thus increasing the company’s customer base in recent years.

Benefits: The report provides complete details about the usage and adoption rate of autoinjectors in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.



  


1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Total Addressable Market 10
2 Report Outline 13
2.1 Report Scope 13
2.2 Report Summary 13
2.3 Research Methodology 14
2.4 Report Assumptions 14
3 Market Snapshot 16
3.1 Market Definition – Infoholic Research 16
3.2 Segmented Addressable Market 16
3.3 Industry Trends 17
3.4 Related Markets 18
3.4.1 Transdermal Drug Delivery 18
3.4.1.1 Trends of cardiovascular drugs market 19
3.4.2 Pulmonary Drug Delivery Systems (PDDS) 19
3.4.3 Insulin Pumps 20
4 Market Outlook 22
4.1 Cost comparison of EpiPen and its Alternatives 22
4.2 Market Segmentation 22
4.3 Porter 5(Five) Forces 23
4.4 PEST Analysis 25
5 Market Characteristics 26
5.1 Market Dynamics 26
5.1.1 Drivers 26
5.1.1.1 Increasing prevalence of Anaphylaxis 26
5.1.1.2 Rising incidence of chronic disease 27
5.1.1.3 Increased Development Biologics / Biosimilars 28
5.1.1.4 Growing demand for home care 28
5.1.2 Opportunities 28
5.1.2.1 Increase in healthcare spending 28
5.1.2.2 Opportunities in emerging market 29
5.1.2.3 Favorable government policies 29
5.1.3 Restraints 30
5.1.3.1 Competition among major vendors 30
5.1.3.2 Increased product recall 30
5.1.3.3 High product pricing 30
5.2 DRO – Impact Analysis 31
5.3 Key Stakeholders 32
6 Application: Market Size and Analysis 33
6.1 Overview 33
6.2 Anaphylaxis 34
6.3 Multiple Sclerosis 35
6.4 Rheumatoid Arthritis 36
6.5 Diabetes 37
6.6 Others 38
7 Product Type: Market Size and Analysis 40
7.1 Overview 40
7.2 Disposable autoinjector 40
7.3 Reusable autoinjectors 41
8 Regions: Market Size and Analysis 43
8.1 Overview 43
8.2 North America 44
8.2.1 Overview 44
8.3 Europe 45
8.3.1 Overview 45
8.4 Asia Pacific 46
8.4.1 Overview 46
8.5 Rest of the World 48
8.5.1 Overview 48
9 Competitive Landscape 49
10 Vendors Profile 51
10.1 Amgen Inc. 51
10.1.1 Overview 51
10.1.2 Geographic Presence 54
10.1.3 Business Focus 55
10.1.4 SWOT Analysis 56
10.1.5 Business Strategies 57
10.2 Becton Dickinson and Company 57
10.2.1 Overview 57
10.2.2 Business Units 60
10.2.3 Geographic Revenue 61
10.2.4 Business Focus 61
10.2.5 SWOT Analysis 61
10.2.6 Business Strategies 62
10.3 Mylan N.V. 62
10.3.1 Overview 62
10.3.2 Business Segments 64
10.3.3 Geographic Presence 66
10.3.4 Business Focus 66
10.3.5 SWOT Analysis 66
10.3.6 Business Strategies 67
10.4 Bayer AG 67
10.4.1 Overview 67
10.4.2 Business Units 69
10.4.3 Geographic Presence 70
10.4.4 Business Focus 71
10.4.5 SWOT Analysis 71
10.4.6 Business Strategies 72
10.5 Eli Lilly & Company Ltd. 72
10.5.1 Overview 72
10.5.2 Business Units 74
10.5.3 Geographic Revenue 75
10.5.4 Business Focus 75
10.5.5 SWOT Analysis 75
10.5.6 Business Strategies 76
10.6 Novartis AG 76
10.6.1 Overview 76
10.6.2 Business Units 80
10.6.3 Geographic Presence 80
10.6.4 Business Focus 81
10.6.5 SWOT Analysis 81
10.6.6 Business Strategies 82
1 Vendors Profile 83
1.1 Ypsomed Holding AG 83
1.1.1 Overview 83
1.2 Biogen Pharmaceuticals 84
1.2.1 Overview 84
1.3 Pfizer Inc. 85
1.3.1 Overview 85
1.3.2 Highlights 87
1.4 Teva Pharmaceutical Industries Ltd. 87
1.4.1 Overview 87
1.5 Antares Pharma, Inc. 89
1.5.1 Overview 89
1.6 Johnson & Johnson 90
1.6.1 Overview 90
1.7 AbbVie Inc. 91
1.7.1 Overview 91
2 Annexure 94
Abbreviations 94


  


List Of Tables



TABLE 1 AUTOINJECTOR MARKET REVENUE BY APPLICATION SEGMENTATION, 2017–2024 ($MILLION) 33
TABLE 2 PREVALENCE OF DIABETES POPULATION FORECASTING BY REGION 37
TABLE 3 AUTOINJECTOR MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 44
TABLE 4 AMGEN INC.: OFFERINGS 51
TABLE 5 AMGEN INC.: RECENT DEVELOPMENTS 51
TABLE 6 BECTON DICKINSON AND COMPANY: OFFERINGS 58
TABLE 7 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 58
TABLE 1 MYLAN N.V.: OFFERINGS 63
TABLE 2 MYLAN N.V.: RECENT DEVELOPMENTS 63
TABLE 3 BAYER AG: OFFERINGS 68
TABLE 4 BAYER AG: RECENT DEVELOPMENTS 68
TABLE 5 ELI LILLY & COMPANY LTD.: PRODUCT OFFERINGS 72
TABLE 6 ELI LILLY & COMPANY LTD.: RECENT DEVELOPMENTS 73
TABLE 7 NOVARTIS AG: OFFERINGS 77
TABLE 8 NOVARTIS AG: RECENT DEVELOPMENTS 78
TABLE 9 YPSOMED HOLDING AG: SNAPSHOT 83
TABLE 10 YPSOMED HOLDING AG: RECENT DEVELOPMENTS 83
TABLE 11 BIOGEN PHARMACEUTICALS: OVERVIEW 84
TABLE 12 BIOGEN PHARMACEUTICALS: RECENT DEVELOPMENTS 84
TABLE 13 PFIZER INC. OVERVIEW 85
TABLE 14 PFIZER INC.: RECENT DEVELOPMENTS 86
TABLE 15 TEVA PHARMACEUTICAL INDUSTRIES LTD. OVERVIEW 87
TABLE 16 TEVA PHARMACEUTICAL INDUSTRIES LTD.: RECENT DEVELOPMENTS 88
TABLE 17 ANTARES PHARMA, INC.: OVERVIEW 89
TABLE 18 ANTARES PHARMA, INC.: RECENT DEVELOPMENTS 89
TABLE 19 JOHNSON & JOHNSON: OVERVIEW 90
TABLE 20 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 90
TABLE 21 ABBVIE INC.: OVERVIEW 91
TABLE 22 ABBVIE INC.: RECENT DEVELOPMENTS 92



  


List Of Figures



CHART 1 RESEARCH METHODOLOGY OF GLOBAL AUTOINJECTOR MARKET 15
CHART 2 GLOBAL AUTOINJECTORS MARKET REVENUE, 2017-2024 ($MILLION) 18
CHART 3 SEGMENTATION OF GLOBAL AUTOINJECTOR MARKET 23
CHART 4 PORTER 5 FORCES OF GLOBAL AUTOINJECTOR MARKET 24
CHART 5 PEST ANALYSIS OF AUTOINJECTOR MARKET 26
CHART 6 MARKET DYNAMICS – DRO ANALYSIS 27
CHART 7 DRO – IMPACT ANALYSIS OF GLOBAL AUTOINJECTORS MARKET 32
CHART 8 KEY STAKEHOLDERS 33
CHART 9 AUTOINJECTOR MARKET SEGMENT REVENUE BY APPLICATION, 2017 VS 2024 ($ MILLION) 34
CHART 10 ANAPHYLAXIS AUTOINJECTOR MARKET REVENUE, BY APPLICATION SEGMENTATION 2017-2024 ($MILLION) 36
CHART 11 MULTIPLE SCLEROSIS AUTOINJECTOR MARKET REVENUE, BY APPLICATION SEGMENTATION 2017-2024 ($MILLION) 36
CHART 12 RHEUMATOID ARTHRITIS MARKET REVENUE, BY APPLICATION SEGMENTATION 2017-2024 ($MILLION) 37
CHART 13 DIABETES AUTOINJECTOR MARKET REVENUE, BY APPLICATION SEGMENTATION 2017-2024 ($MILLION) 39
CHART 14 OTHERS AUTOINJECTOR MARKET REVENUE, BY APPLICATION SEGMENTATION, 2017-2024 ($MILLION) 40
CHART 15 AUTOINJECTOS MARKET SEGMENT SHARE BY TYPE SEGMENTATION, 2017 (%) 41
CHART 16 DISPOSSABLE AUTOINJECTOR MARKET REVENUE, 2017-2024 ($MILLION) 42
CHART 17 REUSABLE AUTOINJECTORS MARKET REVENUE, 2017-2024 ($MILLION) 43
CHART 18 AUTOINJECTOR MARKET BY REGIONAL SEGMENTATION, 2017 (%) 44
CHART 19 AUTOINJECTORS MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION) 46
CHART 20 AUTOINJECTOR MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION) 47
CHART 21 AUTOINJECTORS MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION) 48
CHART 22 AUTO INJECTOR MARKET REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION) 49
CHART 23 AMGEN INC.: OVERVIEW SNAPSHOT 54
CHART 24 AMGEN INC.: GEOGRAPHIC PRESENCE 55
CHART 25 AMGEN INC.: SWOT ANALYSIS 57
CHART 26 BECTON DICKINSON AND COMPANY: OVERVIEW SNAPSHOT 60
CHART 27 BECTON DICKINSON AND COMPANY: BUSINESS UNITS 61
CHART 28 BECTON DICKINSON AND COMPANY: GEOGRAPHIC REVENUE 62
CHART 29 BECTON DICKINSON AND COMPANY: SWOT ANALYSIS 62
CHART 30 MYLAN N.V.: OVERVIEW SNAPSHOT 64
CHART 31 MYLAN N.V.: BUSINESS SEGMENTS 65
CHART 32 MYLAN N.V.: GEOGRAPHIC PRESENCE 67
CHART 33 MYLAN N.V.: SWOT ANALYSIS 67
CHART 34 BAYER AG: OVERVIEW SNAPSHOT 69
CHART 35 BAYER AG: BUSINESS UNITS 70
CHART 36 BAYER AG: GEOGRAPHICAL PRESENCE 71
CHART 37 BAYER AG: SWOT ANALYSIS 72
CHART 38 ELI LILLY & COMPANY LTD.: OVERVIEW SNAPSHOT 74
CHART 39 ELI LILLY & COMPANY LTD.: BUSINESS UNITS 75
CHART 40 ELI LILLY & COMPANY LTD.: GEOGRAPHIC REVENUE 76
CHART 41 ELI LILLY & COMPANY LTD.: SWOT ANALYSIS 76
CHART 42 NOVARTIS AG: OVERVIEW SNAPSHOT 78
CHART 43 NOVARTIS AG: BUSINESS UNITS 81
CHART 44 NOVARTIS AG: GEOGRAPHIC PRESENCE 81
CHART 45 NOVARTIS AG: SWOT ANALYSIS 82


  


Global Autoinjectors Market Research Report Forecast to 2024

Global Autoinjectors Market: Information by Product Type (Disposable, Reusable), Design (Customized, Standardized), by Therapeutic Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others)

USD 4450 View Report

Autoinjectors Market Forecast up to 2024

Global Autoinjectores market report provides complete details about the major challenges that are going to impact on the market growth

USD 3500 View Report

World Cellular M2M market – Technologies & market forecasts up to 2023

World Cellular M2M market Technologies & market forecasts up to 2023 market research report available in single user pdf license with Aarkstore Enterprise at USD 4400

USD 4400 View Report

Global Autoinjectors Market Research Report Forecast to 2024

Global Autoinjectors Market: Information by Product Type (Disposable, Reusable), Design (Customized, Standardized), by Therapeutic Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others)

USD 4450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available